Scholarlink

Background <p>Pancreatic adenocarcinoma (PAAD) represents a highly lethal form of cancer. Mitochondrial stress responses play a critical role in cancer development and therapeutic responses.</p> Methods <p>Transcriptomic and clinical survival data for PAAD and normal pancreatic tissues were sourced from TCGA, GEO, and GTEx databases. Random survival forest and Cox regression analyses were used to identify MOS prognostic genes and construct a prognostic risk model. Subsequently, receiver operating characteristic (ROC) curve analysis, calibration curve analysis, and decision curve analysis were performed to evaluate the model’s performance in both the training and validation sets. Finally, enrichment analysis, protein-protein interaction network construction, unsupervised cluster analysis, tumor immune microenvironment assessment, and chemotherapeutic drug sensitivity analyses were conducted. Finally, we also performed RT-qPCR for validation.</p> Results <p>Five MOS-related genes were identified to construct the risk signature: ABCG1, CENPT, GMNN, NOG, and TOP2A. The predictive performance of the risk signature was validated in both the training set (TCGA) and the test sets (GSE62452 and GSE78229), with areas under the ROC curve for 3-year survival being 0.77, 0.74, and 0.75, respectively. Mechanistically, functional enrichment analysis revealed that pathways associated with cancer cell proliferation and mitochondrial stress responses were upregulated in the high-risk population. Furthermore, specific small molecules may hold therapeutic potential for treating PAAD patients. RT-qPCR results validated the changes in relative RNA expression levels.</p> Conclusion <p>This study demonstrates that mitochondrial oxidative stress is correlated with the prognosis of PAAD and may serve as a novel biomarker and therapeutic target for clinical diagnostics.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Identification of mitochondrial oxidative stress-related genes for estimating prognosis, immune infiltration landscape and drug candidates in pancreatic adenocarcinoma

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月8日

查看全文
  • Ruiguang Ma,
  • Xuechun Liu,
  • Ruining Gong,
  • Yueping Jiang

摘要

Background

Pancreatic adenocarcinoma (PAAD) represents a highly lethal form of cancer. Mitochondrial stress responses play a critical role in cancer development and therapeutic responses.

Methods

Transcriptomic and clinical survival data for PAAD and normal pancreatic tissues were sourced from TCGA, GEO, and GTEx databases. Random survival forest and Cox regression analyses were used to identify MOS prognostic genes and construct a prognostic risk model. Subsequently, receiver operating characteristic (ROC) curve analysis, calibration curve analysis, and decision curve analysis were performed to evaluate the model’s performance in both the training and validation sets. Finally, enrichment analysis, protein-protein interaction network construction, unsupervised cluster analysis, tumor immune microenvironment assessment, and chemotherapeutic drug sensitivity analyses were conducted. Finally, we also performed RT-qPCR for validation.

Results

Five MOS-related genes were identified to construct the risk signature: ABCG1, CENPT, GMNN, NOG, and TOP2A. The predictive performance of the risk signature was validated in both the training set (TCGA) and the test sets (GSE62452 and GSE78229), with areas under the ROC curve for 3-year survival being 0.77, 0.74, and 0.75, respectively. Mechanistically, functional enrichment analysis revealed that pathways associated with cancer cell proliferation and mitochondrial stress responses were upregulated in the high-risk population. Furthermore, specific small molecules may hold therapeutic potential for treating PAAD patients. RT-qPCR results validated the changes in relative RNA expression levels.

Conclusion

This study demonstrates that mitochondrial oxidative stress is correlated with the prognosis of PAAD and may serve as a novel biomarker and therapeutic target for clinical diagnostics.